biotech
Google develops AI to predict cardiovascular risk
February 21, 2018Research and Development AI, Verily Life Sciences, biotech, cardiovascular, drugs, google, pharma, pharmaceutical
Google and Verily Life Sciences, a subsidiary within Alphabet, focused on developing health-tech, have revealed the fruits of a combined …
Apricus shares sink after failed erectile dysfunction application
February 19, 2018Sales and Marketing Apricus, biotech, drugs, pharma, pharmaceutical
Apricus Biosciences had a lot riding on its application to the FDA for its erectile dysfunction cream, Vitaros, with the …
Long-running, $2.5bn lawsuit swings in Gilead’s favour
February 19, 2018Sales and Marketing Gilead, MSD, biotech, drugs, harvoni, pharma, pharmaceutical, sovaldi
The fate of pharma company’s profits and losses largely rests on product approvals and the sales team behind them but, …
AZ’s Imfinzi seals blockbuster lung cancer market with FDA nod
February 19, 2018Sales and Marketing AstraZeneca, Imfinzi, biotech, drugs, pharma, pharmaceutical
AstraZeneca’s immunotherapy, Imfinzi, arrived to the industry as a failure – there were big hopes resting on the company’s Mystic …
Top Ten most popular articles on Pharmafile.com this week
February 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's disease, Roche, Top 10 news, Top ten news, Trump, biotech, drugs, pharma, pharmaceutical
Another week is finished and it’s been a disastrous one for research into a potential treatment for Alzheimer’s disease. Two of …
FDA weighs up divisive change to Alzheimer’s drug assessment
February 16, 2018Medical Communications Alzheimer's, FDA, biotech, drugs, pharma, pharmaceutical
Alzheimer’s disease (AD) is an area badly in need of a treatment, the problem is that this prospect seems to …
Silicon Valley-backed Celgene spin-off launches with $250m
February 16, 2018Medical Communications, Sales and Marketing Celgene, Celularity, biotech, drugs, pharma, pharmaceutical
Biotechs are known for getting off the ground early with serious levels of financing, often based more on the acumen …
Biogen shares hit by key Alzheimer’s drug concerns
February 15, 2018Research and Development Alzheimer's, Biogen, MSD, Merck, biotech, drugs, pharma, pharmaceutical
Biogen made investors very nervous after it announced that it was choosing to add an additional 510 patients to its …
Astellas scoops up Universal Cells for $102.5m
February 15, 2018Sales and Marketing Astellas, Universal Cells, biotech, drugs, pharma, pharmaceutical
Astellas Pharma had only signed an exclusive licensing deal with Universal Cells back in October for the co-development of a …
Lilly posts promising P3 Taltz data
February 14, 2018Research and Development Cosentyx, Eli Lilly, IL-17, Novartis, Taltz, biotech, drugs, pharma, pharmaceutical
The IL-17 market is a crowded space, and one dominated by Novartis’ Cosentyx. Eli Lilly is attempting to challenge that, …
Pfizer taps real world evidence for CVD in new partnership
February 14, 2018Research and Development BC Platforms, Pfizer, biotech, cardiovascular disease, drugs, pharma, pharmaceutical
BC Platforms, a company that focuses on genomic data managements and analysis, has announced that it has partnered with Pfizer …
Bill & Melinda Gates Foundation shows faith in CureVac
February 14, 2018Research and Development, Sales and Marketing Bill & Melinda Gates foundation, biotech, drugs, influenza, pharma, pharmaceutical
The Bill & Melina Gates Foundation had already invested $52 million in CureVac, back in 2015, and has now doubled …
Vertex gets approval for combo-therapy in cystic fibrosis
February 13, 2018Manufacturing and Production, Sales and Marketing Vertex, biotech, cystic fibrosis, drugs, pharma, pharmaceutical
All eyes are on Vertex’s two Phase 3 trials into a triple therapy for cystic fibrosis (CF), in the meantime, …
Purdue pulls plug on opioid marketing
February 13, 2018Manufacturing and Production, Sales and Marketing Purdue Pharma, biotech, drugs, opioid, opioid epidemic, pharma, pharmaceutical
Purdue Pharma was fined $643.5 million in 2007 for its part in creating the opioid epidemic that has plagued the …
New flu med can destroy influenza virus in one day
February 13, 2018Manufacturing and Production, Research and Development Roche, Shionongi, Tamiflu, biotech, drugs, flu, influenza, pharma, pharmaceutical
Researchers in Japan have achieved a notable success in a Phase 3 clinical trial to determine whether a new vaccine …
Latest content
